05/28/2025
4:25 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2025
4:23 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
05/22/2025
3:38 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
3:37 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:16 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2025
3:39 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:32 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2025
4:13 PM | Kiniksa Pharmaceuticals (Subject)
Patel Sanj K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2025
3:47 PM | Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:49 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:50 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for KNSA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kiniksa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
05/05/2025
3:52 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:53 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:54 PM | Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:26 PM | Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:24 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
4:10 PM | Kiniksa Pharmaceuticals (Subject)
Moat Ross (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2025
4:11 PM | Kiniksa Pharmaceuticals (Subject)
Ragosa Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2025
3:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2025
6:40 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
6:47 PM | BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/23/2025
3:31 PM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
3:44 PM | Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:30 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
04/16/2025
3:38 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
3:39 PM | Kiniksa Pharmaceuticals (Filer)
| Form PRE 14A | |
04/09/2025
3:41 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:42 PM | Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:43 PM | Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:44 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:45 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:45 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
5:57 PM | Kiniksa Pharmaceuticals (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G | |
04/03/2025
4:06 PM | Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:52 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
3:35 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:48 PM | Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:49 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:50 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:51 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:52 PM | Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Only a handful of people know the setup that's defied these chaotic markets. (Ad) Since February, we've hit 28 out of 29 trades – that's a 96% win rate taking simple options setups on one single ticker every day.
That's why Jack Carter and I teamed up to reveal The 4PM Payout Plan.
Our goal here was to show you how to take these daily setups every morning to collect a 4PM payout.
Naturally, no one can guarantee what the market does in the future…
But these simple daily options setups have paid out with the market rallying, dropping, or staying flat.
And if you want to be one of the few to not just know the ropes behind these daily setups but also deploy them for yourself… Go here now to get started on what could become your first 4PM payout. |
03/19/2025
4:53 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:29 PM | Kiniksa Pharmaceuticals (Subject)
Ragosa Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025
3:37 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:38 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
3:47 PM | Kiniksa Pharmaceuticals (Subject)
Megna Michael R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2025
3:37 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
4:13 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025
3:31 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/25/2025
3:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2025
6:31 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
2:45 PM | Fairmount Funds Management LLC (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
4:37 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
3:42 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:27 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
6:34 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
3:45 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
4:17 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
3:34 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
6:14 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:25 PM | Kiniksa Pharmaceuticals (Subject)
Ragosa Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
4:13 PM | Kiniksa Pharmaceuticals (Subject)
Megna Michael R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
4:50 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
3:32 PM | HHLR ADVISORS, LTD. (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
3:30 PM | Kiniksa Pharmaceuticals (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
11/06/2024
3:11 PM | Kiniksa Pharmaceuticals (Subject)
Patel Sanj K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
3:14 PM | Kiniksa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
6:31 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SC 13G | |
10/17/2024
3:35 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:57 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
4:29 PM | BAKER BROS. ADVISORS LP (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SC 13D/A | |
10/08/2024
4:08 PM | Boyd Meta Cantey (Reporting)
Kiniksa Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
3:40 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:14 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Kiniksa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:39 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
4:02 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
7:57 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:51 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:52 PM | Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:53 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:55 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:42 PM | Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
4:16 PM | Kiniksa Pharmaceuticals (Subject)
Paolini John F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
4:17 PM | Kiniksa Pharmaceuticals (Subject)
Moat Ross (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
3:36 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
4:17 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024
3:31 PM | Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
3:32 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
3:33 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
3:10 PM | Kiniksa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad) So, unless you’ve been living under a rock, you probably saw the news…
Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯
We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer. 🎯 Click here to watch the video and get the free ticker XGPT just flagged. |
07/23/2024
6:54 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/04/2024
11:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form EFFECT | |
07/04/2024
11:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form EFFECT | |
06/30/2024
11:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form EFFECT | |
06/28/2024
4:29 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/28/2024
4:30 PM | Kiniksa Pharmaceuticals (Filer)
| Form 15-15D | |
06/28/2024
4:22 PM | Kiniksa Pharmaceuticals (Filer)
| Form POS AM | |
06/28/2024
4:22 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/28/2024
4:23 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
Buy KNSA Stock Free KNSA Stock Alerts